Superior Effectiveness of Tofacitinib Compared to Vedolizumab in Anti-TNF-experienced Ulcerative Colitis Patients: A Nationwide Dutch Registry Study
Tessa Straatmijer(Leiden University Medical Center), Joep Grootjans, Hayat el Ghabzouri, Noortje Festen(University Medical Center Groningen), Adriaan A. van Bodegraven(Zuyderland Medisch Centrum), Mark Löwenberg(Amsterdam University Medical Centers), Bas Oldenburg(University Medical Center Utrecht), Nidhi Srivastava, Sander van der Marel(Medisch Centrum Haaglanden), Jael Smid, Marieke Pierik(Maastricht University Medical Centre), Martine van Workum, Zlatan Mujagic(Maastricht University Medical Centre), Frank Hoentjen(Radboud University Nijmegen), Rob H. Creemers(Zuyderland Medisch Centrum), Toos Schakel- van den Berge, Alexander Bodelier(Amphia Ziekenhuis), Suzanne C. Gerretsen, Nynke Boontje, Rosaline Theeuwen(Leiden University), Andrea E. van der Meulen‐de Jong(Leiden University Medical Center), Kamila Talhaoui, Cyriel Y. Ponsioen(Amsterdam UMC Location University of Amsterdam), Carmen S. Horjus(Rijnstate Hospital), Vince Biemans(Radboud University Nijmegen), Geert D’Haens(Amsterdam University Medical Centers), Denise van den Berg, Marijn C. Visschedijk(University Medical Center Groningen), J van der Woude(Erasmus University Rotterdam), Gerard Dijkstra(University Medical Center Groningen), Willemijn van Dop, Marthe François-Verweij, Bindia Jharap(Meander Medisch Centrum), Xenia Yocarini, Malena Schlotter, Marjolijn Duijvestein(Amsterdam University Medical Centers), Tessa E H Römkens(Jeroen Bosch Ziekenhuis), Jeroen Maljaars(Leiden University Medical Center), Dirk de Jong(University Medical Center Groningen), Rachel West(Sint Franciscus Gasthuis), Jeroen M. Jansen(OLVG), Herma H. Fidder(University Medical Center Utrecht), Meike M. Hirdes(University Medical Center Utrecht), J. H. Hoekstra(Radboud University Nijmegen), Annemarie de Vries(Erasmus University Rotterdam), Fiona D.M. van Schaik(University Medical Center Utrecht), Michael M.P. J.A. van der Voorn(Haga Hospital), Nanne K.H. de Boer, Wout Mares(Ziekenhuis Gelderse Vallei), Marije D.J. Wolvers(Amsterdam University Medical Centers)
Cited by 51
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Causal relationships among the gut microbiome, short-chain fatty acids and metabolic diseases
|Nature Genetics|2019|1.6k
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
|Gastroenterology|1998|865